๐ฐ Cigna News
Page 222 - Cigna News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cigna. Real-time updates on events, politics, business and more.
May 1, 2023
When the COVID-19 public health emergency ends this month, coronavirus tests will still be available, but there will be changes to who pays for them.
May 1, 2023
When the COVID-19 public health emergency ends this month, coronavirus tests will still be available, but there will be changes to who pays for them.
April 30, 2023
The U.S.-Kenya partnership is strong, built on sixty years of shared values and interests.
April 30, 2023
A proposed bill in the state House would grant the stateโs biggest non-profit insurer broad leeway to operate like a for-profit company.
April 30, 2023
Pune (Maharashtra) [India]/ Bellevue (Washington) [US], April 28 (ANI/PRNewswire): Icertis today announced that artificial intelligence (AI) was applied to nearly 50 per cent more contracts on its platform in 2022 compared to the previous year. This affirms continued momentum behind AI adoption in contract-driven processes as forward-looking enterprises seek to transform operations, inform strategic decision-making, and realize the full intent of their commercial agreements with contract intelli...
April 29, 2023
Could insurance pay for your hearing aids? Here is your all-in-one guide to hearing care benefits across insurance programs in the United States.
April 29, 2023
With so many market-moving parts, expect some volatility next week.
April 28, 2023
Pune (Maharashtra) [India]/ Bellevue (Washington) [US], April 28 (ANI/PRNewswire): Icertis today announced that artificial intelligence (AI) was applied to nearly 50 per cent more contracts on its platform in 2022 compared to the previous year
April 28, 2023
In a research note, Goldman Sachs analyst Michele della Vigna has maintained his recommendation on the stock with a Buy rating. The target price continues to be set at EUR 18. | April 28, 2023
April 28, 2023
Already positive, the research from Goldman Sachs and its analyst Michele della Vigna still consider the stock as a Buy opportunity. The target price is slightly modified from 20.60 to 21.00 NOK. | April 28, 2023